Green Orbit Pharmatrading Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 89.94%
- Ebitda 89.94%
- Net Worth -10.00%
- Total Assets -2.90%
About Green Orbit Pharmatrading
Green Orbit Pharmatrading Private Limited (GOPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2011 and has a history of 13 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mirza Feroz and Venkata Muttanapalli serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01403TG2011PTC076179
-
Company No.
076179
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Green Orbit Pharmatrading?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mirza Feroz
|
Director | 25-Aug-2011 | Current |
|
Venkata Muttanapalli
|
Additional Director | 09-Oct-2021 | Current |
Financial Performance of Green Orbit Pharmatrading.
Green Orbit Pharmatrading Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 89.94% increase in profit. The company's net worth by .
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Orbit Pharmatrading?
In 2019, Green Orbit Pharmatrading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bioreform Private LimitedMirza Feroz is a mutual person
-
Inv Plastocons Private Limited
Mirza Feroz is a mutual person
-
Edventure Incubation Foundation
Mirza Feroz is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Orbit Pharmatrading?
Unlock and access historical data on people associated with Green Orbit Pharmatrading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Orbit Pharmatrading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Orbit Pharmatrading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
